Disclosures
Royalties received from Arthrex, Inc., Medbridge
Speaker for
Paid Consultant for Arthrex, Inc
Stock received from VuMedi
Support received from Arthrex, Inc, Ossur America, Siemens, Smith & Nephew
Financial Support received from Proof Point Biologics: Co-owner
Royalties or support received from Springer
All relevant financial disclosures have been mitigated.
Disclosures complete: Aug 31, 2022
*Please note that Global Link resources are not part of the CME offered for the 2025 ISAKOS Congress.